There will be some revenue but I bet the costs involved in all this deal making will be enormous. I can only imagine the accountant fees and lawyer cost. Remember the MSO was on hold and Excellegen sales have just started. Next quarter should be a lot better. Revenue and expenses for the deal making. Going to have lots of sales people on the payroll too.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links